Cargando…
Psychometric performance of the Kannada version of sarcopenia quality of life questionnaire (SarQoL(®))
BACKGROUND: The Sarcopenia Quality of Life (SarQoL®) is a patient reported quality-of-life questionnaire specific to sarcopenia. In the Indian context, its availability is limited to Hindi, Marathi and Bengali vernacular languages. AIMS: This study aimed to translate, cross-culturally adapt the SarQ...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10236591/ https://www.ncbi.nlm.nih.gov/pubmed/37268903 http://dx.doi.org/10.1186/s12891-023-06559-8 |
_version_ | 1785052969796894720 |
---|---|
author | Kumar, Prabal Umakanth, Shashikiran Girish, N |
author_facet | Kumar, Prabal Umakanth, Shashikiran Girish, N |
author_sort | Kumar, Prabal |
collection | PubMed |
description | BACKGROUND: The Sarcopenia Quality of Life (SarQoL®) is a patient reported quality-of-life questionnaire specific to sarcopenia. In the Indian context, its availability is limited to Hindi, Marathi and Bengali vernacular languages. AIMS: This study aimed to translate, cross-culturally adapt the SarQoL® questionnaire into Kannada and investigate its psychometric properties. METHODS: The SarQoL®-English version was translated into Kannada with the developer’s permission and in accordance with their requirements. To validate the discriminative power, internal consistency and floor and ceiling effect of the SarQoL®-Kannada questionnaire were assessed in the first step. In the second step, the construct validity and the test–retest reliability of the SarQoL®-Kannada was determined. RESULT: There was no difficulty in the translation process. A total of n = 114 participants (sarcopenic participants n = 45 and n = 69 non-sarcopenic participants) were included. The good discriminative power of the SarQoL®-Kannada questionnaire {quality of life for sarcopenic subjects [56.43 ± 11.32] vs. non-sarcopenic ones [79.38 ± 8.16], p < 0.001}. High internal consistency (Cronbach’s alpha coefficient was 0.904) and no ceiling/ floor effect were reflected. Excellent test–retest reliability (intraclass correlation coefficient was 0.97, 95% CI 0.92–0.98) were found. A good convergent and divergent validity with similar and different domains of WHOQOL-BREF was observed, while EQ-5D-3L had good convergent and weak divergent validity. CONCLUSION: The SarQoL®-Kannada questionnaire is valid, consistent and reliable for the measurement of quality of life of sarcopenic participants. SarQoL®-Kannada questionnaire is now available to be used in clinical practice and as a treatment outcome indicator in research. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12891-023-06559-8. |
format | Online Article Text |
id | pubmed-10236591 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-102365912023-06-03 Psychometric performance of the Kannada version of sarcopenia quality of life questionnaire (SarQoL(®)) Kumar, Prabal Umakanth, Shashikiran Girish, N BMC Musculoskelet Disord Research BACKGROUND: The Sarcopenia Quality of Life (SarQoL®) is a patient reported quality-of-life questionnaire specific to sarcopenia. In the Indian context, its availability is limited to Hindi, Marathi and Bengali vernacular languages. AIMS: This study aimed to translate, cross-culturally adapt the SarQoL® questionnaire into Kannada and investigate its psychometric properties. METHODS: The SarQoL®-English version was translated into Kannada with the developer’s permission and in accordance with their requirements. To validate the discriminative power, internal consistency and floor and ceiling effect of the SarQoL®-Kannada questionnaire were assessed in the first step. In the second step, the construct validity and the test–retest reliability of the SarQoL®-Kannada was determined. RESULT: There was no difficulty in the translation process. A total of n = 114 participants (sarcopenic participants n = 45 and n = 69 non-sarcopenic participants) were included. The good discriminative power of the SarQoL®-Kannada questionnaire {quality of life for sarcopenic subjects [56.43 ± 11.32] vs. non-sarcopenic ones [79.38 ± 8.16], p < 0.001}. High internal consistency (Cronbach’s alpha coefficient was 0.904) and no ceiling/ floor effect were reflected. Excellent test–retest reliability (intraclass correlation coefficient was 0.97, 95% CI 0.92–0.98) were found. A good convergent and divergent validity with similar and different domains of WHOQOL-BREF was observed, while EQ-5D-3L had good convergent and weak divergent validity. CONCLUSION: The SarQoL®-Kannada questionnaire is valid, consistent and reliable for the measurement of quality of life of sarcopenic participants. SarQoL®-Kannada questionnaire is now available to be used in clinical practice and as a treatment outcome indicator in research. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12891-023-06559-8. BioMed Central 2023-06-02 /pmc/articles/PMC10236591/ /pubmed/37268903 http://dx.doi.org/10.1186/s12891-023-06559-8 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Kumar, Prabal Umakanth, Shashikiran Girish, N Psychometric performance of the Kannada version of sarcopenia quality of life questionnaire (SarQoL(®)) |
title | Psychometric performance of the Kannada version of sarcopenia quality of life questionnaire (SarQoL(®)) |
title_full | Psychometric performance of the Kannada version of sarcopenia quality of life questionnaire (SarQoL(®)) |
title_fullStr | Psychometric performance of the Kannada version of sarcopenia quality of life questionnaire (SarQoL(®)) |
title_full_unstemmed | Psychometric performance of the Kannada version of sarcopenia quality of life questionnaire (SarQoL(®)) |
title_short | Psychometric performance of the Kannada version of sarcopenia quality of life questionnaire (SarQoL(®)) |
title_sort | psychometric performance of the kannada version of sarcopenia quality of life questionnaire (sarqol(®)) |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10236591/ https://www.ncbi.nlm.nih.gov/pubmed/37268903 http://dx.doi.org/10.1186/s12891-023-06559-8 |
work_keys_str_mv | AT kumarprabal psychometricperformanceofthekannadaversionofsarcopeniaqualityoflifequestionnairesarqol AT umakanthshashikiran psychometricperformanceofthekannadaversionofsarcopeniaqualityoflifequestionnairesarqol AT girishn psychometricperformanceofthekannadaversionofsarcopeniaqualityoflifequestionnairesarqol |